Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions

Ince, ALİ TÜZÜNYILDIZ, KemalBAYSAL, BirolDANALIOGLU, AhmetKOCAMAN, OrhanTOZLU, MukaddesGANGARAPU, VenkatanarayanaKemik, Ahu SarbayUysal, OmerSenturk, HAKAN2019-10-052019-10-052014-04-01Ince A. T. , YILDIZ K., BAYSAL B., DANALIOGLU A., KOCAMAN O., TOZLU M., GANGARAPU V., Kemik A. S. , Uysal O., Senturk H., -Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions-, TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.25, ss.162-169, 2014https://hdl.handle.net/20.500.12645/2948Background/Aims: Despite the presence of many diagnostic methods, the differential diagnosis between benign and malignant biliary obstructions is still not easy. We aimed to evaluate the role of serum/biliary carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), vascular endothelial growth factor receptor-3(VEGFR-3), and total antioxidant capacity (TAC) tests in this differential diagnosis.eninfo:eu-repo/semantics/openAccessRoles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructionsArticleWOS:0003393103000088490551204910.5152/tjg.2014.605625003676